Trials / Unknown
UnknownNCT03534908
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: the Correlation Analysis and Risk Prediction Model Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000,000 (estimated)
- Sponsor
- Wuhan University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world. NAFLD is associated with a lot of comorbidity, such as diabetes, metabolic syndrome, coronary heart disease and chronic kidney diseases. However, the correlation between the NAFLD and cardiovascular disease (CVD) events remains controversial. This study is an observational study based on a big retrospective cohort in china to explore the prevalence of NAFLD in China, the risk factors associated with NAFLD, as well as whether patients with NAFLD are more prone to experience CVDs and CVD events.
Conditions
Timeline
- Start date
- 2017-09-25
- Primary completion
- 2020-09-30
- Completion
- 2021-06-30
- First posted
- 2018-05-23
- Last updated
- 2019-10-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03534908. Inclusion in this directory is not an endorsement.